[HTML][HTML] Effect of oral semaglutide on cardiovascular parameters and their mechanisms in patients with type 2 diabetes: Rationale and design of the Semaglutide Anti …
M Janić, M Rizzo, F Cosentino, A Pantea Stoian… - Diabetes Therapy, 2022 - Springer
Abstract Introduction Type 2 diabetes (T2D) management has reached a point where not
only optimal glycaemic control is necessary, but also additional interventions with proven …
only optimal glycaemic control is necessary, but also additional interventions with proven …
[HTML][HTML] Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide …
M Janić, M Rizzo, F Cosentino, AP Stoian… - Diabetes …, 2022 - ncbi.nlm.nih.gov
Methods A total of 100 consecutive patients with T2D and a disease duration of up to 10
years, without manifest cardiovascular disease, who are treated with metformin …
years, without manifest cardiovascular disease, who are treated with metformin …
Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti …
M Janić, M Rizzo, F Cosentino… - … and education of …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Type 2 diabetes (T2D) management has reached a point where not only optimal
glycaemic control is necessary, but also additional interventions with proven cardiovascular …
glycaemic control is necessary, but also additional interventions with proven cardiovascular …
[PDF][PDF] Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide …
M Janic, MRF Cosentino, APSML Mišo, ŠA Janez - researchgate.net
ABSTRACT Introduction: Type 2 diabetes (T2D) management has reached a point where
not only optimal glycaemic control is necessary, but also additional interventions with proven …
not only optimal glycaemic control is necessary, but also additional interventions with proven …
Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti …
M Janić, M Rizzo, F Cosentino, M Lunder… - … and Education of …, 2022 - europepmc.org
Methods A total of 100 consecutive patients with T2D and a disease duration of up to 10
years, without manifest cardiovascular disease, who are treated with metformin …
years, without manifest cardiovascular disease, who are treated with metformin …
[PDF][PDF] Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide …
M Janic, MRF Cosentino, APSML Mišo, ŠA Janez - iris.unipa.it
ABSTRACT Introduction: Type 2 diabetes (T2D) management has reached a point where
not only optimal glycaemic control is necessary, but also additional interventions with proven …
not only optimal glycaemic control is necessary, but also additional interventions with proven …
Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti …
M Janić, M Rizzo, F Cosentino… - Diabetes …, 2022 - search.ebscohost.com
Abstract Introduction: Type 2 diabetes (T2D) management has reached a point where not
only optimal glycaemic control is necessary, but also additional interventions with proven …
only optimal glycaemic control is necessary, but also additional interventions with proven …
Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti …
M Janić, M Rizzo, F Cosentino, A Pantea Stoian… - DIABETES …, 2022 - iris.unipa.it
Abstract Introduction Type 2 diabetes (T2D) management has reached a point where not
only optimal glycaemic control is necessary, but also additional interventions with proven …
only optimal glycaemic control is necessary, but also additional interventions with proven …
Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti …
M Janić, M Rizzo, F Cosentino, M Lunder… - … and Education of …, 2022 - europepmc.org
Methods A total of 100 consecutive patients with T2D and a disease duration of up to 10
years, without manifest cardiovascular disease, who are treated with metformin …
years, without manifest cardiovascular disease, who are treated with metformin …